
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Income Statement | ||||||
Revenue | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | -- | |
Current Liabilities | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | -- | |
Total Debt | -- | -- | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Cash Flow Statement | ||||||
Cash Flow Operations | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Free Cash Flow | -- | -- | -- | -- | -- |
In the current month, IGIB has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IGIB average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that iShares 5-10 Yr Investment Grade Corporate Bd ETF share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about iShares 5-10 Yr Investment Grade Corporate Bd ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iShares 5-10 Yr Investment Grade Corporate Bd ETF is a Sell and believe this share price will rise from its current level to --.
The price target for iShares 5-10 Yr Investment Grade Corporate Bd ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for iShares 5-10 Yr Investment Grade Corporate Bd ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of iShares 5-10 Yr Investment Grade Corporate Bd ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iShares 5-10 Yr Investment Grade Corporate Bd ETF shares.
iShares 5-10 Yr Investment Grade Corporate Bd ETF was last trading at $52.76 per share. This represents the most recent stock quote for iShares 5-10 Yr Investment Grade Corporate Bd ETF. Yesterday, iShares 5-10 Yr Investment Grade Corporate Bd ETF closed at $52.68 per share.
In order to purchase iShares 5-10 Yr Investment Grade Corporate Bd ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.